Works matching IS 09546820 AND DT 2021 AND VI 289 AND IP 3

Results: 19

Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 404, doi. 10.1111/joim.13230

By:

Rassouli, F.;
Germann, A.;
Baty, F.;
Kohler, M.;
Stolz, D.;
Thurnheer, R.;
Brack, T.;
Kähler, C.;
Widmer, S.;
Tschirren, U.;
Sievi, N. A.;
Tamm, M.;
Brutsche, M. H.

Publication type:

Article

The pathogenesis of microthrombi in COVID‐19 cannot be controlled by DOAC: NETosis should be the target.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 420, doi. 10.1111/joim.13228

By:

Gremese, E.;
Ferraccioli, G.

Publication type:

Article

Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?"'.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 427, doi. 10.1111/joim.13166

By:

Pineton de Chambrun, M.;
Frere, C.;
Miyara, M.;
Amoura, Z.;
Martin‐Toutain, I.;
Mathian, A.;
Hekimian, G.;
Combes, A.

Publication type:

Article

Direct oral anticoagulant use and risk of severe COVID‐19.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 411, doi. 10.1111/joim.13205

By:

Flam, B.;
Wintzell, V.;
Ludvigsson, J. F.;
Mårtensson, J.;
Pasternak, B.

Publication type:

Article

A contemporary review of Clostridioides difficile infections in patients with haematologic diseases.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 293, doi. 10.1111/joim.13173

By:

Dutta, D.;
Jafri, F.;
Stuhr, D.;
Knoll, B. M.;
Lim, S. H.

Publication type:

Article

Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID‐19: experience from London.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 385, doi. 10.1111/joim.13172

By:

Vaid, N.;
Ardissino, M.;
Reed, T. A. N.;
Goodall, J.;
Utting, P.;
Miscampbell, M.;
Condurache, D.;
Cohen, D. L.

Publication type:

Article

Systemic amyloidosis from A (AA) to T (ATTR): a review.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 268, doi. 10.1111/joim.13169

By:

Muchtar, E.;
Dispenzieri, A.;
Magen, H.;
Grogan, M.;
Mauermann, M.;
McPhail, E. D.;
Kurtin, P. J.;
Leung, N.;
Buadi, F. K.;
Dingli, D.;
Kumar, S. K.;
Gertz, M. A.

Publication type:

Article

Prognostic significance of present atrial fibrillation on a single office electrocardiogram in patients with atrial fibrillation.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 395, doi. 10.1111/joim.13168

By:

Krisai, P.;
Hämmerle, P.;
Blum, S.;
Meyre, P.;
Aeschbacher, S.;
Melchiorre‐Mayer, P.;
Baretella, O.;
Rodondi, N.;
Conen, D.;
Osswald, S.;
Kühne, M.;
Zuern, C. S.

Publication type:

Article

Coronary artery calcium scoring: an evidence‐based guide for primary care physicians.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 309, doi. 10.1111/joim.13176

By:

Cheong, B. Y. C.;
Wilson, J. M.;
Spann, S. J.;
Pettigrew, R. I.;
Preventza, O. A.;
Muthupillai, R.

Publication type:

Article

Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 369, doi. 10.1111/joim.13165

By:

Savarese, G.;
Hage, C.;
Benson, L.;
Schrage, B.;
Thorvaldsen, T.;
Lundberg, A.;
Fudim, M.;
Linde, C.;
Dahlström, U.;
Rosano, G. M. C.;
Lund, L. H.

Publication type:

Article

Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 430, doi. 10.1111/joim.13163

By:

Patel, K.;
Gooley, T. A.;
Bailey, N.;
Bailey, M.;
Hegerova, L.;
Batchelder, A.;
Holdread, H.;
Dunleavy, V.;
Downey, T.;
Frisvold, J.;
Megrath, S.;
Pagarigan, K.;
Szeto, J.;
Rueda, J.;
Islam, A.;
Maree, C.;
Nyatsatsang, S.;
Bork, S. E.;
Lipke, A.;
O'Mahony, D. S.

Publication type:

Article

Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID‐19: a retrospective cohort study.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 434, doi. 10.1111/joim.13162

By:

Eimer, J.;
Vesterbacka, J.;
Svensson, A.‐K.;
Stojanovic, B.;
Wagrell, C.;
Sönnerborg, A.;
Nowak, P.

Publication type:

Article

Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 355, doi. 10.1111/joim.13161

By:

Gynnild, M. N.;
Aakerøy, R.;
Spigset, O.;
Askim, T.;
Beyer, M. K.;
Ihle‐Hansen, H.;
Munthe‐Kaas, R.;
Knapskog, A. B.;
Lydersen, S.;
Næss, H.;
Røsstad, T.G.;
Seljeseth, Y. M.;
Thingstad, P.;
Saltvedt, I.;
Ellekjær, H.

Publication type:

Article

Reply to "High frequency of Antiphospholipid Antibodies in Critically ill COVID‐19 patients: a Link with Hypercoagulability?".

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 425, doi. 10.1111/joim.13159

By:

Suárez‐Pérez, L.;
Coto‐Hernández, R.;
Suárez‐Cuervo, C.;
Caminal‐Montero, L.

Publication type:

Article

A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 340, doi. 10.1111/joim.13157

By:

Van Olden, C. C.;
Van de Laar, A. W.;
Meijnikman, A. S.;
Aydin, O.;
Van Olst, N.;
Hoozemans, J. B.;
De Brauw, L. M.;
Bruin, S. C.;
Acherman, Y. I. Z.;
Verheij, J.;
Pyykkö, J. E.;
Hagedoorn, M.;
Sanderman, R.;
Bosma, N. C.;
Tremaroli, V.;
Lundqvist, A.;
Olofsson, L. E.;
Herrema, H.;
Lappa, D.;
Hjorth, S.

Publication type:

Article

High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 422, doi. 10.1111/joim.13126

By:

Pineton de Chambrun, M.;
Frere, C.;
Miyara, M.;
Amoura, Z.;
Martin‐Toutain, I.;
Mathian, A.;
Hekimian, G.;
Combes, A.

Publication type:

Article

Issue Information.

Published in:: Journal of Internal Medicine, 2021, v. 289, n. 3, p. 267, doi. 10.1111/joim.13104
Publication type:: Article

Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases.

Published in:

Journal of Internal Medicine, 2021, v. 289, n. 3, p. 325, doi. 10.1111/joim.13114

By:

Valerio, L.;
Zane, F.;
Sacco, C.;
Granziera, S.;
Nicoletti, T.;
Russo, M.;
Corsi, G.;
Holm, K.;
Hotz, M.‐A.;
Righini, C.;
Karkos, P. D.;
Mahmoudpour, S. H.;
Kucher, N.;
Verhamme, P.;
Di Nisio, M.;
Centor, R. M.;
Konstantinides, S. V.;
Pecci, A.;
Barco, S.

Publication type:

Article

Lemierre syndrome - treat with antibiotics, anticoagulants or both?

Published in:

2021

By:

Schulman, S.

Publication type:

Editorial